Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure

Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure

Introduction: HBV is major health problem globally due to complications, including ACLF, cirrhosis and hepa¬tocellular carcinoma. ACLF due to exacerbation of CHB is associate with 30%-70% mortality. Reduction of HBV-DNA is therefore a target of therapy in ACLF-B. Methods: Patients with spontaneous r...

Full description

Bibliographic Details
Main Authors: Abul H Manik, Debraj Malakar, Sheikh M Noor-E-Alam, Mamun A Mahtab, Dulal C Das, Ayub A Mamun, Sakirul Khan, Mohammad Fazle Akbar, Zakiur Rahman, Salimur Rahman
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
aclf-b
monotherapy
telbivudine
tenofovir
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2021;volume=10;issue=6;spage=2376;epage=2380;aulast=Manik

Internet

http://www.jfmpc.com/article.asp?issn=2249-4863;year=2021;volume=10;issue=6;spage=2376;epage=2380;aulast=Manik

Similar Items